Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 21, 2020Circulation

Glucagon-Like Peptide 1 Receptor Agonists and Heart Failure

View Full Paper
Ask AI
Bookmark
Share

Authors

MKMuhammad Shahzeb KhanNorthwestern UniversityGregg C. FonarowGregg C. FonarowHeart Failure / CardiomyopathyDarren K. McGuireDarren K. McGuireGeneral / Preventive / Lipids

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Khan et al. (2020) studied this question.

synapsesocial.com/papers/6986412629958b2750b9d64dhttps://doi.org/10.1161/circulationaha.120.045888
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Heart rate, beta-blocker use, and outcomes of heart failure with reduced ejection fraction2018 · 33 citations
  2. 2The incidence of congestive heart failure associated with antidiabetic therapies2004 · 105 citations
  3. 3Trends in Noncardiovascular Comorbidities Among Patients Hospitalized for Heart Failure2018 · 173 citations
  4. 4Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 20172018 · 14,266 citations
  5. 5Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control2016 · 503 citations